Intec pharma ltd. (NTEC)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Jun'18Dec'17Dec'16
Assets
CURRENT ASSETS:
Cash and cash equivalents

10,892

9,292

14,966

20,796

31,497

39,246

-

53,393

-

Investment in marketable securities (Note 3)

-

770

767

762

757

1,333

-

1,825

-

Prepaid expenses and other receivables

2,638

3,683

2,453

3,072

2,685

2,986

-

1,125

-

TOTAL CURRENT ASSETS

13,530

13,745

18,186

24,630

34,939

43,565

-

56,343

-

NON-CURRENT ASSETS:
Property and equipment, net

2,272

2,575

6,200

12,455

12,487

12,233

-

8,206

-

Operating lease right-of-use assets

1,117

1,243

1,687

1,859

2,047

-

-

-

-

Other assets (Note 4a)

3,717

3,717

4,204

7,487

6,792

5,431

-

-

-

Deferred tax assets (Note 9)

-

-

504

429

350

281

-

-

-

TOTAL NON-CURRENT ASSETS

7,106

7,535

12,595

22,230

21,676

17,945

-

8,206

-

Cash and cash equivalents

-

-

-

-

-

-

64,481

-

16,376

Financial assets at fair value through profit or loss

-

-

-

-

-

-

1,670

-

1,852

Restricted bank deposits

-

-

-

-

-

-

147

-

62

Other receivables

-

-

-

-

-

-

2,869

-

2,384

TOTAL CURRENT ASSETS

-

-

-

-

-

-

69,167

-

20,674

Other assets

-

-

-

-

-

-

1,696

-

-

Property and equipment

-

-

-

-

-

-

12,143

-

4,047

TOTAL NON-CURRENT ASSETS

-

-

-

-

-

-

13,839

-

-

TOTAL ASSETS

20,636

21,280

30,781

46,860

56,615

61,510

83,006

64,549

24,721

Liabilities and shareholders' equity
CURRENT LIABILITIES -
Accounts payable and accruals: Trade

930

3,507

4,834

2,331

3,487

2,849

-

1,854

-

Accounts payable and accruals: Other (Note 6)

4,187

4,835

6,774

7,679

7,245

4,807

-

3,893

-

TOTAL CURRENT LIABILITIES

5,117

8,342

11,608

10,010

10,732

7,656

-

5,747

-

LONG-TERM LIABILITIES -
Operating lease liabilities

647

799

1,132

1,269

1,409

-

-

-

-

Other liabilities

652

604

554

472

385

309

-

-

-

TOTAL LONG-TERM LIABILITIES

1,299

1,403

1,686

1,741

1,794

309

-

-

-

Trade

-

-

-

-

-

-

5,256

-

1,152

Other

-

-

-

-

-

-

4,079

-

768

TOTAL CURRENT LIABILITIES

-

-

-

-

-

-

9,335

-

1,920

Derivative financial instruments

-

-

-

-

-

-

-

-

97

TOTAL LIABILITIES

6,416

9,745

13,294

11,751

12,526

7,965

-

5,747

2,017

SHAREHOLDERS' EQUITY:
Ordinary shares, with no par value - authorized: 100,000,000 Ordinary Shares as of March 31, 2020 and December 31, 2019; issued and outstanding: 52,973,580 and 35,892,209 Ordinary Shares as of March 31, 2020 and December 31, 2019, respectively

727

727

727

727

727

727

-

727

-

Additional paid-in capital

206,786

200,231

199,627

196,871

195,842

194,642

-

156,356

-

Accumulated deficit

-193,293

-189,423

-182,867

-162,489

-152,480

-141,824

-

-98,281

-

TOTAL SHAREHOLDERS' EQUITY

14,220

11,535

17,487

35,109

44,089

53,545

-

58,802

-

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

20,636

21,280

30,781

46,860

56,615

61,510

-

64,549

-

Ordinary shares

-

-

-

-

-

-

727

-

727

Share premium

-

-

-

-

-

-

183,998

-

84,980

Currency translation differences

-

-

-

-

-

-

-378

-

-378

Accumulated deficit

-

-

-

-

-

-

-110,676

-

-62,625

TOTAL EQUITY

-

-

-

-

-

-

73,671

-

22,704

TOTAL LIABILITIES AND EQUITY

-

-

-

-

-

-

83,006

-

24,721